John Shiver, Ph.D.
About John Shiver, Ph.D.
John Shiver, Ph.D., serves as the Chief Strategy Officer for the Infectious Diseases Business Unit at IGM Biosciences, Inc. and is a member of the Board of Directors at Icosavax, Inc., bringing extensive academic and industry experience to his roles.
Current Role at IGM Biosciences
John Shiver, Ph.D. serves as the Chief Strategy Officer for the Infectious Diseases Business Unit at IGM Biosciences, Inc. He has held this position since 2021. In this role, he focuses on developing strategic initiatives to advance the company's efforts in combating infectious diseases. His work contributes to the overall mission of IGM Biosciences in the biopharmaceutical sector.
Board Membership at Icosavax, Inc.
Since 2022, John Shiver has been a member of the Board of Directors at Icosavax, Inc. His involvement in the board reflects his expertise in the field of infectious diseases and strategic business development. This role allows him to influence the direction of the company and contribute to its governance.
Academic Position at University of Pennsylvania
John Shiver has been an Adjunct Professor at the College of Medicine at the University of Pennsylvania since 2008. In this capacity, he engages with students and faculty, sharing his knowledge and experience in the field of infectious diseases and biochemistry. His academic role complements his professional endeavors in the biopharmaceutical industry.
Educational Background
John Shiver earned his Ph.D. in Chemistry from the University of Florida. Prior to this, he completed his Bachelor of Science in Chemistry and Mathematics at Wofford College. His educational background provides a strong foundation for his work in the fields of infectious diseases and biopharmaceutical strategy.